Skip to main content

Guselkemab vs. Ustekinumab in PsA: Dr. Richard Conway

Nov 09, 2021 1:59 pm

Dr. Conway discusses abstract #1773 presented at the ACR21 annual meeting.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×